Two experiments were conducted to determine the effect of an encapsulated sodium butyrate (Na-B) with targeted releasing times on broiler performance, energy digestibility, intestinal morphology, and ceca Salmonella colonization. In experiment 1, 3 different Na-B products (CMA, CMP, and CMS) were evaluated following a challenge with a nalidixic acid-resistant Salmonella typhimurium (ST NAR ). CobbCobb male birds were placed 8 per pen into 6 replicates for each treatment. Treatments included 6 Na-B treatments (500 and 1,000 ppm of each product) plus 2 control (non-challenged and challenged). Birds were orally gavaged with 0.1 mL of 10 7 cfu/mL ST NAR on d 4. Ceca and ileal samples were collected on d 11. In experiment 2, CMA and CMP products were evaluated for a full grow-out period without an external challenge. CobbCobb male birds were distributed among 45 floor pens with 24 birds per pen. Treatments included 4 product treatments (500 and 1,000 ppm of each product) plus one control. Feed intake and pen weight were obtained on d 14, 28, and 42. Experiment 1 showed that CMP at 1,000 ppm had the highest value for BW and BWG on d 4 (P = 0.07). Adding CMA and CMP at 500 ppm increased ileal digestibility energy (IDE) compared to the challenged control (P ≤ 0.05). The Salmonella recovery data indicated that the challenge had a significant but mild impact, since it did not affect the performance variables but did result in a significant increase in log 10 cfu/g cecal material between the nonchallenged and challenged control (1.42 vs 3.72). Experiment 2 showed that both products improved the villus height in the duodenum on d 21 (P = 0.08) and IDE on d 42, relative to the control (P ≤ 0.05). This study demonstrates that Na-B has the potential to improve growth in broilers at an early age. The beneficial effects on intestinal morphology and IDE are affected not only by dosage level, but also by the product's releasing time.
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INTRODUCTION
Short chain fatty acids (SCFA) are considered a potential alternative to antibiotics in feed (Leeson et al., 2005) . In animals, SCFA are the end product of the fermentation of non-starch polysaccharide and unabsorbed starch by anaerobic bacteria (Scheppach, 1994) , with acetic acid, propionic acid, and butyric acid as the major constituents (Bugaut, 1987) . With respect to butyric acid, it has been shown that it has an important role in growth performance, intestinal epithelium development, and antimicrobial effects in poultry (Leeson et al., 2005) . Previous research has shown the positive effect of adding butyric acid on both body weight gain (BWG) and feed convention ratio (FCR) in broilers (Levy et al., 2015) . Butyrate also may serve as an energy source for enterocytes (Mahdavi and Torki, 2009) which can increase villus growth and overall absorptive surface area in the intestine (Guilloteau et al., 2010) . In addition, butyric acid also inhibits Salmonella colonization in the ceca (Cox et al., 1994) and downregulates the gene expression and invasion of Salmonella (Van Immerseel et al., 2006) .
In practice, most butyric acid products are used as a sodium or calcium salt because of the volatile and pungent nature of butyric acid (Kaczmarek et al., 2016) . Studies have shown that butyrate is easily absorbed in the upper gastrointestinal (GI) tract when fed in the free salt form (Bolton and Dewar, 1965; Van der Wielen, 2002) . The butyric acid salt needs to be in an undissociated state before reaching the hindgut to exert its antimicrobial effect (Warnecke and Gill, 2005) . The common method to protect sodium butyrate (Na-B) from early GI tract absorption is to use palm stearin or other vegetable fat to encapsulate the Na-B and control its releasing time in the GI tract.
The small intestine plays an important role in nutrient digestion and absorption (Svihus, 2014) . The cecum is the major site for unabsorbed nutrient fermentation and exerts essential effects to maintain gut microbiota balance (Svihus et al., 2013) . Studies have shown that earlier releasing of products in the small intestine can stimulate villi development and nutrient digestibility, and later releasing time in the cecum has an inhibitory effect on gut bacteria (Fernández-Rubio et at., 2009; Guilloteau et al., 2010) . Liu et al. (2017) used a computed tomography technology and developed a precision-fed digestive rate-of-passage assay in broilers under non-fasted state. The assay suggested that 30 min to 2.5 h post ingestion releasing is the appropriate time for the encapsulated products aimed at stimulating epithelial cell development and improving nutrient digestibility in the small intestine, and 2.5 to 4 h releasing would be an optimal range for products that focus on hindgut bacterial control.
The aim of this study was to determine the effects of adding an encapsulated Na-B with targeted releasing times on broiler performance, energy digestibility, intestinal morphology, and ceca Salmonella colonization.
MATERIAL AND METHODS
The protocol used in this study was approved by the University of Georgia Animal Care and Use Committee, and Biosafety Committee. Both experiments were conducted at the University of Georgia Poultry Research Center, with birds obtained on the d of hatch from Cobb-Vantress hatchery in Cleveland, Georgia.
Experimental design and animal husbandry
In Experiment 1 (EXP 1), a total of 384 Cobb-Cobb male broilers was housed in 2 Petersime battery brooder units in a thermostatically controlled room. Three Na-B products (CMA, CMP, and CMS) were encapsulated, and the varying releasing times were verified by an in-vitro assessment (King Techina Technology Co., Ltd, Hangzhou, China), targeting 2 h releasing (CMA), 3-4 h releasing (CMP), and over 5 h releasing (CMS) times. The experimental design consisted of 8 treatments: non-challenged control, challenged control, CMA (500 ppm and 1,000 ppm), CMP (500 ppm and 1,000 ppm), and CMS (500 ppm and 1,000 ppm) with 6 replicate pens for each dietary treatment. At study initiation, 8 birds were randomly allocated to each treatment pen. Initial pen weights were controlled to be within ± 10 grams of the entire mean flock weight of 8 birds. All birds were allowed ad libitum access to feed and water with 24 h light.
In Experiment 2 (EXP 2), a total of 1,080 CobbCobb male broilers was allotted into 45 floor pens (1.22 × 1.83 m 2 each) with used pine shaving litter for bedding. Only CMA (2 h releasing time) and CMP (3-4 h releasing time) products were included in EXP 2. The experimental design consisted of 5 treatments: control, CMA (500 ppm and 1,000 ppm), and CMP (500 ppm and 1,000 ppm) with 9 replicates for each dietary treatment. Initially, 24 birds were randomly allocated to each treatment pen, and pen weights were controlled to be within ± 25 grams of the entire mean flock weight of 24 birds. The broilers were given a 3-phase feeding program, including starter (one to 14 d), grower (15 to 28 d), and finisher (29 to 42 d) phases. Feed was provided as mash in the starter phase and as pellets during the grower and finisher phases. All birds were allowed ad libitum access to feed and water.
For both experiments, birds were observed twice per d in regard to general flock condition, unanticipated events for the house, and mortality for each pen.
Dietary treatments
A basal, industry-type broiler starter diet was used in EXP 1 (Table 1 ). The diet was divided into 8 equally sized portions, creating a total of 8 dietary treatments as outlined under the experimental design. Titanium dioxide (TiO 2 , 0.2%) was used as an indigestible marker.
In EXP 2, the basal diets were formulated with 3,080 kcal ME/kg, 22% CP; 3,100 kcal ME/kg, 20% CP; and 3,150 kcal ME/kg, 18.5% CP for starter, grower, and finisher phases, respectively (Table 2) . TiO 2 (0.2%) was used as an indigestible marker for the last 5 d of the experiment. 
Growth data and sample collection
For EXP 1, total pen and feed weights were recorded at the start of the experiment. On d 4, all challenge treatment birds were orally gavaged with 0.1 mL × 10 7 cfu/mL nalidixic acid-resistant Salmonella typhimurium (ST NAR ). Diets were fed for a period of 11 d, with pen BW and feed intake (FI) measured on d 4 and 11 for determination of BWG and FCR, adjusted for mortality. Five birds per pen were randomly selected for ileal digesta content, ileal tissue, and ceca samples for ST NAR colonization. For EXP 2, pen BW and FI were recorded on d 14, 28, and 42 of the experimental period. The duodenum, jejunum, and ileum tissue samples from random 6 birds per treatment (one bird per random pen) were collected on d 21 and 42 for intestinal morphology. On d 42, one bird per pen was randomly selected for ileal digesta collection.
Salmonella recovery
In EXP 1, the cecum of one bird per pen from the non-challenged control and challenged control treatments was aseptically sampled on d 7 to confirm Salmonella colonization. On d 11, all birds were euthanized by carbon dioxide, and 5 pairs of ceca per pen were collected and placed in stomacher bags for ST NAR colonization. Individual ceca were weighed and diluted 1:3 with buffered peptone water, stomached for 60 s, and spread plated with 3 swabs onto BGS-Nal plates (Blanchfield et al., 1984) . All plates and ceca were incubated overnight at 37
• C. Then, the plates from the restreaked plates were read for negative samples and colonizing factor (CF).
Digestibility and ileal histology
Ileal digesta were collected for energy digestibility. All samples were dried at 100
• C for 24 h and ground for analysis (Campasino et al., 2015) . Feed and digesta were evaluated for CP and gross energy (GE) using AOAC methods (2006). TiO 2 concentration was determined using a modified procedure outlined by Short et al. (1996) at the University of Georgia Agricultural and Environmental Services Laboratories (Feed and Environmental Water Laboratory, Athens, Georgia). The following equations were used to calculate ileal digestibility energy (IDE) and ileal energy digestible coefficient (IEDC) (Scott et al., 1982) :
Where: NT represents kcal in the sample, Ti represents the percentage of titanium, with the subscript "i" representing the ileal contents and subscripts "d" representing the diet.
In EXP 1, the ileal tissues were collected on d 11. In EXP 2, the duodenum, jejunum, and ileum tissues were collected on both d 21 and 42 for quantifying intestinal histology. After collection, all tissues were immediately placed in 10% neutral buffered formalin. After fixation, tissues were cut into cassettes and routinely processed overnight. Samples were then embedded in paraffin, sectioned at 4 microns, placed on slides, and then stained with hematoxylin and eosin and cover slipped. Villus height and crypt depth were measured using methods by Kik et al. (1990) and the ImageJ software (National Institutes of Health) at the Poultry Diagnostic and Research Center Histology Laboratory (Athens, Georgia).
Statistical analysis
All data from EXP 1 and 2 were analyzed by one-way ANOVA using GLM producer via the JMP 13.0 (SAS Institute; Cary, NC). Means were deemed significant at P ≤ 0.05 and were separated by Tukey's HSD test. The standard error of the mean was adopted as the measure of error.
RESULTS
In EXP 1, the performance results (Table 3) showed an increasing trend on growth when adding Na-B in the diet compared with the control treatment, where CMP at 1,000 ppm had the highest BW and BWG value (P = 0.07) on d 4. On d 11, the same general trends were seen, but there was not a significant effect on BW, BWG, or FCR among any of the treatments after the Salmonella challenge. Table 4 shows the IDE results for birds post ST NAR challenge. There was a significant 10% decrease in IDE once the birds were challenged with Salmonella. Both CMA and CMP products improved the energy digestibility compared with the challenged control treatment. CMA and CMP at 500 ppm resulted in a significantly higher digestibility (P ≤ 0.05) than the other treatments. For ileal morphology results (Table 5) , adding CMA at 500 ppm and CMP at 1,000 ppm resulted in a significantly higher (P ≤ 0.05) villus height than any other treatment. However, there was no significant effect on the villus height to crypt depth ratio among different treatments. On d 7, we had approximately log 10 2.8 cfu/g of cecal material in the challenge control treatment. Based on this, we considered that the challenge was successful. The Salmonella colonization results from the ceca are shown in Table 6 . The challenge had a significant effect (P ≤ 0.05), with log 10 cfu/g cecal material showing an increase between the non-challenged and challenged control treatments (1.42 vs. 3.72). However, between the different product treatments, there were no significant differences in Salmonella colonization.
In EXP 2, there was no significant effect on growth performance when adding Na-B in the absence of an experimental challenge environment on d 14, 28, and 42. Table 7 shows the IDE and IEDC for broilers reared to 42 d of age. The CMA at 500 ppm and CMP products had significantly higher (P ≤ 0.01) IDE than the control treatment. The morphology results from d 21 are shown in Table 8 . On d 21, both CMA and CMP product treatments had a higher (P = 0.08) villus height in the duodenum than the control treatment. CMA at 500 ppm showed the highest (P = 0.06) villus height in the jejunum compared with other treatments. For the villus height to crypt depth ratio in the ileum, the control treatment showed the lowest value (P ≤ 0.05), compared to the other treatments. However, there were no significant differences on villus height, crypt depth, or villus height to crypt depth ratio on d 42, among all the treatments.
DISCUSSION
The SCFA are the fatty acids with an aliphatic tail of less than 6 carbon atoms. Butyrate products (including the acid and salt forms) are considered as one of the antibiotic growth promoter (AGP) alternative feed additives (Leeson et al., 2005) . From EXP 1, we found the CMP (3-4 h releasing time) added at 1,000 ppm can improve the BW and BWG at an early age. Birds at younger ages may be more sensitive to Na-B effects, because the SCFA levels are low in the intestine of the young birds (Van der Wielen et al., 2000) . Levy et al. (2015) did not find significant increase in BWG when adding butyric acid only at 100 ppm, which illustrates the importance of dosage level for Na-B products. However, in the current study, there were no significant differences for FCR among treatments after the Salmonella challenge. Hu and Guo (2007) showed a significant increase effect in BWG, but no effect on FCR when adding Na-B in the diet through 21 d, because Na-B can increase the average daily body mass and FI at the same time. Other researchers found that butyrate improved the FCR in pigs (Manzanilla et al., 2006) . Sodium butyrate improved the animals' health status and increased the nutrient use efficiency. The butyrate supplementations delayed the gastric emptying time, slowed down the digesta flow rate, and optimized pH of the gastric digesta in the GI tract (Guilloteau et al., 2010) . EXP 1 also found that CMA (2 h releasing time) and CMP added at 500 ppm significantly increased the IDE when compared to the other challenged treatments. The same results on improved energy digestibility were found in EXP 2, that both CMA and CMP product treatments significantly improved the IDE compared with the control. The IDE results from EXP 1 and 2 were closed to a similar study using a protected calcium butyrate (Kaczmarek et al., 2016) , in which the product increased apparent total tract crude fat digestibility and AMEn. The authors thought that the butyrate salt may improve the secretion of pancreatic fluid, which can affect the digestibility of crude fat and AMEn. Fernández-Rubio et al. (2009) showed that partially protected Na-B provides a unique balance of free and protected active substances that are effective throughout the GI tract. The CMS product had lower IDE and IEDC compared with other Na-B treatments, which proved that >5 h releasing time is too long for the encapsulated Na-B to have effect in the broiler's GI tract (Liu et al., 2017) .
According to the intestinal morphology results in EXP 1, CMA at 500 ppm and CMP at 1,000 ppm had the highest villus height (P ≤ 0.05). In EXP 2, all product treatments had a higher (P = 0.08) villus height in the duodenum, and CMA at 500 ppm showed the highest (P = 0.06) villus height in the jejunum. Also, both product treatments significantly improved the villus height to crypt depth ratio (P ≤ 0.05) in the ileum on d 21. The beneficial effects on intestinal morphology are explained by Biagi et al. (2007) . The SCFA provides carbons that can serve as an energy source for epithelial cells in the intestine (Mahdavi and Torki, 2009) . It improved the villus growth, increased the nutrient absorption surface area, which overall affected the nutrient digestibility and BW. However, there were no significant differences for intestinal morphology results on d 42, which may be because the intestine is fully developed at the older age (Levy et al., 2015) . In addition, even the birds in EXP 2 were raised with used litter, but without any external challenge. Levy et al. (2015) also found no difference in the duodenum and jejunum morphology results when adding butyric acid in the diet on d 42, due to the birds also not being involved in an external challenge. For the Salmonella colonization results, under this mild challenge condition within the 11 d experimental period of EXP 1, all different releasing time products showed no significant influence on Salmonella colonization. Cox et al. (1994) found a significant decrease (P ≤ 0.05) on ceca Salmonella colonization with adding butyric acid on d 21. Other researchers (Fernández-Rubio et al., 2009 ) also have showed a significant decrease (P ≤ 0.05) on the infection in different organs (crop, cecum, and liver) when birds were challenged with Salmonella Enteritidis. Butyrate is the end fermentation product of non-starch polysaccharide, which is very important for the ceca microbiota population and balance in chickens. The undissociated forms of butyrate acid can penetrate the cell membrane of the bacteria (Van Immerseel et al., 2004) . It can dissociate into anions and protons, change the intracellular micro-pH environment, and downregulate the gene expression and invasion of Salmonella (Van Immerseel et al., 2006) , which leads to an inhibition effect on bacteria growth (Ricke, 2003) . Na-B also promotes the microbiota diversity and induces the competitive exclusion effect between the beneficial and pathogenic bacteria (Manzanilla et al., 2006; Jerzsele et al. 2012) . Based on the results from EXP 1, it may be that a short experimental time period and mild challenge were not able to lead to a significant influence on the Salmonella colonization results.
In conclusion, this study demonstrates that Na-B has the potential to improve BW and BWG in broilers at an early age. An earlier releasing product can increase the villus growth and IDE. However, a later releasing product, targeted to control the hindgut microbial population, did not show significant influence on Salmonella control under the current experimental condition. The beneficial effects of Na-B on intestinal morphology and IDE from both studies, indicate that Na-B can positively influence the intestinal absorptive surface area, which can be affected not only by dosage, but also by the product's targeted releasing time.
